Jul 17, 2026
284:263
For every 263 shares held, investors received 284. The price per share adjusted from $33.25 to $30.79.
The split itself did not change the total investment value.
Synmosa Biopharma Corp (TPEX:4114) operates in the Pharmaceuticals: major industry.
Synmosa Biopharma Corp company overviewSynmosa Biopharma Corp's most recent stock split was on July 17, 2026. It was a 284-for-263 forward split, so shareholders received 284 shares for every 263 they held.
Synmosa Biopharma Corp (TPEX:4114) has split its stock 18 times: a 26-for-25 split on September 19, 2005, a 26-for-25 split on September 14, 2006, a 53-for-50 split on December 11, 2008, a 21-for-20 split on September 30, 2011, a 21-for-20 split on August 31, 2012, a 55-for-54 split on June 20, 2016, a 118-for-99 split on August 10, 2017, a 11-for-10 split on August 9, 2018, a 409-for-359 split on July 11, 2019, a 423-for-394 split on July 9, 2020, a 649-for-579 split on September 23, 2021, a 163-for-148 split on July 11, 2022, a 579-for-574 split on May 26, 2023, a 200-for-183 split on August 8, 2023, a 11-for-10 split on August 9, 2024, a 715-for-711 split on February 3, 2025, a 727-for-661 split on July 11, 2025, and a 284-for-263 split on July 17, 2026.
Synmosa Biopharma Corp has split its stock 18 times. This history records 18 forward splits between September 19, 2005 and July 17, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Synmosa Biopharma Corp's 284-for-263 split on July 17, 2026, every 263 shares became 284 shares.
Synmosa Biopharma Corp has not announced a new split in our records. Its most recent split was on July 17, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:4114 split will appear on this page.
Already premium?